BHARAT IMMUNOLOGICALS & BIOLOG Share Price

BHARAT IMMUNOLOGICALS & BIOLOG Share Price

BSE: 524663
|
Pharmaceuticals
|
S Cap
₹ 13.40
-₹0.57 (-4.08%)
1D
Last updated 23 Sep, 2026, 15:29 IST

BHARAT IMMUNOLOGICALS & BIOLOG Share Price Today

As of 24 Sep 2026, BHARAT IMMUNOLOGICALS & BIOLOG share price is ₹13.40. The stock opened at ₹13.98, compared to its previous close of ₹13.97. During today's trading session, BHARAT IMMUNOLOGICALS & BIOLOG share price moved in the range of ₹13.10 to ₹14.05, with an average price of ₹13.57 for the day. Looking at its last 52-week, the stock has touched a low of ₹13.10 and a high of ₹22.61.

₹13.10
4.08% down today
₹14.05
1D LOW
1D HIGH

BHARAT IMMUNOLOGICALS & BIOLOG Returns Calculator

Circuit
L
H
₹11.18
₹16.76
52-week
L
H
₹13.10
₹22.61

About BHARAT IMMUNOLOGICALS & BIOLOG

BHARAT IMMUNOLOGICALS & BIOLOG Share Price
ISIN
INE994B01014
Sector Market Cap
₹ 60.32 Cr

Bharat Immunologicals and Biologicals Corporation Limited is an India-based biotechnology company. The Company is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. It operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. It is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The Company is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). It is also diversified into plasma-derived medicines and Oral Cholera vaccines. The Company's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BHARAT IMMUNOLOGICALS & BIOLOG Financial Highlights

  • Revenue: BHARAT IMMUNOLOGICALS & BIOLOG reported revenue of ₹45.67 crore in FY23 vs ₹79.49 crore in FY22. It showed a decrease of 42.55% on a yearly basis.
  • Operating Profit: BHARAT IMMUNOLOGICALS & BIOLOG reported an operating loss of ₹22.27 crore in FY23 vs ₹9.69 crore in FY22. It showed a decrease of 129.82% on a year-on-year basis.
  • Net Profit: BHARAT IMMUNOLOGICALS & BIOLOG reported a net loss of ₹16.64 crore in FY23 vs ₹8.75 crore in FY22. It showed a decrease of 90.17% on a yearly basis.

BHARAT IMMUNOLOGICALS & BIOLOG Quarterly Result Highlights

  • BHARAT IMMUNOLOGICALS & BIOLOG reported revenue of ₹0.16 crore in Sep 2023, compared with ₹0.10 crore in Jun 2023, representing an increase of 60.00% on a quarter-on-quarter (QoQ) basis.
  • BHARAT IMMUNOLOGICALS & BIOLOG reported an operating loss of ₹6.65 crore in Sep 2023, compared with ₹5.97 crore in Jun 2023, representing a decrease of 11.39% on a quarter-on-quarter (QoQ) basis.
  • BHARAT IMMUNOLOGICALS & BIOLOG reported a loss of ₹4.92 crore in Sep 2023, compared with ₹4.59 crore in Jun 2023, reflecting a decrease of 7.19% on a QoQ basis.
  • The earnings per share (EPS) of BHARAT IMMUNOLOGICALS & BIOLOG stood at ₹3.95 during Sep 2023.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
59.25%
FII
0.00%
Other DII
0.00%
Retail and other
40.75%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20230.00%
Sep 20230.00%
Dec 20230.00%
Mar 20240.00%
Mkt Cap Cr
57.95
P/E
-3.34
P/B
-4.09
ROE
-22.95%
D/E
0.94
ROCE
-11.16%
Div. Yield
0.00%
EPS(TTM)
-3.85
Turnover
0.04
EV/EBITDA
-7.43
Net Margin
-38.24%
Op. Margin
-35.10%
ROA
-9.61%
Quick Ratio
0.35
Curr. Ratio
1.16
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bharat Immunolog has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bharat Immunolog appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BHARAT IMMUNOLOGICALS & BIOLOG Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Revenue₹44.61₹78.39₹85.33₹66.84
Other Income₹2.80₹1.10₹1.68₹1.18
Total Revenue₹47.41₹79.49₹87.01₹68.02
Total Expenses₹70.26₹89.18₹111.22₹82.22
Profit Before Tax-₹22.85-₹9.69-₹24.21-₹14.20
Tax-₹5.79-₹0.93-₹6.10-₹3.99
Profit After Tax-₹17.06-₹8.75-₹18.11-₹10.21
EPS - Basic-₹3.95-₹2.03₹1.10-₹2.36
EPS - Diluted-₹3.95-₹2.03₹1.10-₹2.36

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Profit before tax-₹22.85-₹9.69-₹24.21-₹14.20
Income before WC changes-₹16.13-₹4.41₹11.82-₹10.13
Change in Assets₹28.86-₹24.54₹60.63₹2.46
Change in Liabilities-₹1.84-₹13.16-₹60.67₹41.75
Change in WC₹27.02-₹37.70-₹0.04₹44.21
Cash flow from Operations₹10.89-₹42.12₹11.78₹34.08
Cash flow from Investing₹0.46₹0.53₹0.67₹0.91
Cash flow from Financing-₹14.71₹45.00-₹12.20-₹34.41
Total Cash Flow-₹3.36₹3.42₹0.24₹0.58
Cash (Start of the year)₹4.64₹1.23₹0.99₹0.41
Cash (End of the year)₹1.29₹4.64₹1.23₹0.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Non-Current Assets₹152.60₹147.30₹70.03₹33.81
Current Assets₹33.06₹65.43₹33.95₹93.02
Total Assets₹185.66₹212.73₹103.99₹126.83
Current Liabilities₹91.44₹101.26₹64.09₹100.71
Net Current Asset-₹58.38-₹35.83-₹30.14-₹7.69
Non-Current Liabilities₹6.42₹6.11₹5.85₹5.65
Equity Capital₹87.80₹105.35₹34.04₹20.47
Total Equity & Liabilities₹185.66₹212.73₹103.99₹126.83
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
13.4
500
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 500
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
2
Bullish
3
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
23.72
Bearish
ATR (14)
0.87
Neutral
STOCH(9,6)
6.12
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
25.99
Bearish
UO(9)
34.02
Neutral
ROC(12)
-12.65
Bearish
WillR(14)
-93.88
Bullish
Period
Simple value
Exponential vaue
5D
14
13.98
10D
14.55
14.38
20D
15.05
14.85
50D
15.65
15.55
100D
16.5
16.18
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
BHARAT IMMUNOLOGICALS & BIOLOG Share Price
BHARAT IMMUNOLOGICALS & BIOLOG
Pharmaceuticals
Add Stock
Add Another

BHARAT IMMUNOLOGICALS & BIOLOG Share Price FAQs

BHARAT IMMUNOLOGICALS & BIOLOG share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837